News Releases

Advanced Search
  • Nov 8, 2022
    Third Quarter Revenue Growth of 2%

    BEDFORD, Mass., November 8, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its third...

  • Nov 1, 2022
    Study Demonstrated Superiority of Cingal, a Single-Injection Hyaluronic Acid-Based Viscosupplement Combined with Fast-Acting Steroid, Over Steroid Alone, for Osteoarthritis Pain Relief at 26 Weeks

    BEDFORD, Mass., November 1, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced that Cingal® met its...

  • Oct 25, 2022

    BEDFORD, Mass., October 25, 2022 -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue...

  • Sep 12, 2022
    X-Twist expands Anika’s sports medicine portfolio with a cornerstone suture anchor system ideal for key repairs in the shoulder, foot and ankle, and other extremities

    BEDFORD, Mass., September 12, 2022-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced the limited market...

  • Aug 3, 2022
    Second quarter revenue growth up 4%
    X-Twist™ 510(k) clearance received; Limited market release on schedule for 2H 2022

    BEDFORD, Mass., August 3, 2022 – Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its second...

Show 5102550100 per page
To Top